Enjoy complimentary customisation on priority with our Enterprise License!
The POC HbA1C testing market has the potential to grow by USD 203.16 million during 2020-2024, and the market’s growth momentum will accelerate at a CAGR of 8.50%.
This POC HbA1C testing market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentations by product (consumables and instruments) and geography (APAC, Europe, North America, and ROW). The POC HbA1C testing market report also offers information on several market vendors, including Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corp., EKF Diagnostics Holdings Plc, F. Hoffmann-La Roche Ltd, HUMAN Gesellschaft für Biochemica und Diagnostica mbH, OSANG Healthcare, Quest Diagnostics Inc., Siemens Healthineers AG, and Tosoh Corp. among others.
Browse TOC and LoE with selected illustrations and example pages of POC HbA1C Testing Market
Based on our research output, there has been a neutral impact on the market growth during and post COVID-19 era. The rise in the prevalence of diabetes is notably driving the POC HbA1C testing market growth. To unlock information on the key market drivers and the COVID-19 pandemic impact on the POC HbA1C testing market get your FREE report sample now.
This POC HbA1C testing market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. Get detailed insights on the trends and challenges, which will help companies evaluate and develop growth strategies.
The report analyzes the market’s competitive landscape and offers information on several market vendors, including:
The POC HbA1C testing market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market. Click here to uncover other successful business strategies deployed by the vendors.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
Download a free sample of the POC HbA1C testing market forecast report for insights on complete key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
For more insights on the market share of various regions Request for a FREE sample now!
35% of the market’s growth will originate from North America during the forecast period. The US and Canada are the key markets for POC HbA1C testing in North America.
The report offers an up-to-date analysis of the geographical composition of the market. North America has been recording a significant growth rate and is expected to offer several growth opportunities to market vendors during the forecast period. To garner further competitive intelligence and regional opportunities in store for vendors, view our sample report.
To gain further insights on the market contribution of various segments Request for a FREE sample
The POC HbA1C testing market share growth by the consumables segment has been significant. This report provides insights on the impact of the unprecedented outbreak of COVID-19 on market segments. Through these insights, you can safely deduce transformation patterns in consumer behavior, which is crucial to gauge segment-wise revenue growth during 2020-2024 and embrace technologies to improve business efficiency.
Request for a free sample of the report to get an exclusive glimpse of actionable market insights on post COVID-19 impact on each segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the POC HbA1C testing market size.
We can help! Our analysts can customize this report to meet your requirements. Get in touch
POC HbA1C Testing Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2019 |
Forecast period |
2020-2024 |
Growth momentum & CAGR |
Accelerate at a CAGR of 9% |
Market growth 2020-2024 |
$ 203.16 million |
Market structure |
Fragmented |
YoY growth (%) |
8.40 |
Regional analysis |
APAC, Europe, North America, and ROW |
Performing market contribution |
North America at 35% |
Key consumer countries |
the US and Canada |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corp., EKF Diagnostics Holdings Plc, F. Hoffmann-La Roche Ltd, HUMAN Gesellschaft für Biochemica und Diagnostica mbH, OSANG Healthcare, Quest Diagnostics Inc., Siemens Healthineers AG, and Tosoh Corp. |
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period, |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.